Platelet count-agnostic methods of treating myelofibrosis

Reanalysis of the SIMPLIFY 1 and 2 trials data indicates MMB is effective in JAKi- naïve patients and in second line therapy to RUX, providing benefits of reducing enlarged spleens, improving myelofibrosis-related symptoms, and increasing transfusion independence in patient at risk for thrombocytope...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	KLENCKE, Barbara Jane, DONAHUE, Rafe Michael Joseph, SMITH, Gregg David
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!